Bicycle Therapeutics (NASDAQ:BCYC – Free Report) had its price objective decreased by Oppenheimer from $44.00 to $36.00 in a research report released on Wednesday morning,Benzinga reports. Oppenheimer currently has an outperform rating on the stock. A number of other research analysts also recently issued reports on the stock. Weiss Ratings reiterated a “sell (e+)” rating […]

Bicycle Therapeutics (NASDAQ:BCYC – Free Report) had its price objective lowered by Citizens Jmp from $12.00 to $8.00 in a report published on Wednesday,Benzinga reports. The firm currently has a market outperform rating on the stock. Other research analysts also recently issued reports about the company. Weiss Ratings restated a “sell (e+)” rating on shares […]

Netskope (NASDAQ:NTSK – Get Free Report) had its price objective decreased by research analysts at Citizens Jmp from $27.00 to $23.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has a “market outperform” rating on the stock. Citizens Jmp’s price objective points to a potential upside of 89.61% from the company’s […]